Kirby McInerney LLP is investigating potential claims against Accenture plc on behalf of investors concerning possible violations of federal securities laws. The investigation focuses on whether the company and its senior management issued false or misleading statements or failed to disclose material information. This scrutiny follows Accenture cutting its fiscal year 2026 revenue growth forecast to 3-4%, down from the previously projected range of 3-5%, which caused its shares to tumble 18% on June 18, 2026.

The guidance revision on June 18, 2026, confirmed that the growth trajectory management had projected three months earlier was no longer achievable. Third quarter revenue of $18.7 billion fell short of analyst expectations of $18.78 billion. Prior to the earnings report, Morgan Stanley downgraded Accenture to Hold on June 16, 2026, reducing its price target from $240 to $177 over concerns that anticipated AI spending rationalization had not materialized.

Accenture's prior guidance, issued during its fiscal Q2 earnings report on March 19, 2026, had projected 3-5% revenue growth for full-year fiscal 2026, uplifted from Q1’s previous 2-5% target. The significant drop in share price, a decline of $28.03 per share to close at $127.98, has prompted the legal review to assess potential breaches of fiduciary duties or regulatory compliance standards. The firm is examining the period leading up to the guidance cut to determine if investors were misled about the company's financial health or business prospects.

Key Details of the Investigation

Investors who purchased or otherwise acquired Accenture securities are encouraged to participate in the investigation. Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. Shareholders can contact Lauren Molinaro via email at investigations@kmllp.com or by telephone at 212-699-1171 to discuss their rights or interests at no cost.

Mizuho analyst Dan Dolev has maintained an Outperform rating on Accenture (NYSE: ACN) while lowering the price target to $226 from $280. Separately, TD Cowen analyst Bryan Bergin maintained a Hold rating on the stock and raised the price target to $151 from $150. These adjustments reflect revised valuation outlooks for the information technology services and consulting firm.

The retention of the Outperform rating by Mizuho suggests continued confidence in Accenture's long-term performance despite the reduced price objective. The new target of $226 represents a significant decrease from the previous $280 level. Meanwhile, TD Cowen's modest increase to $151 accompanies a Hold stance.

Analyst Rating and Target Changes

The following table outlines the revised metrics provided by the analysts:

Accenture operates in the global professional services market, providing strategy, consulting, digital, technology, and operations services. The stock trades on the New York Stock Exchange under the ticker symbol ACN.